Gross Profit Summary of Fujian Cosunter Pharmaceutical Co., Ltd.

Fujian Cosunter Pharmaceutical Co., Ltd.'s latest annual gross profit in 2023 was 236.17 Million CNY , up 6.9% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd.'s latest quarterly gross profit in 2024 Q3 was 65.86 Million CNY , up 6.3% from previous quarter.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a annual gross profit of 226.99 Million CNY in annual gross profit 2022, down -2.2% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a annual gross profit of 232.09 Million CNY in annual gross profit 2021, down -4.8% from previous year.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a quarterly gross profit of 65.86 Million CNY for 2024 Q3, up 6.3% from previous quarter.
Fujian Cosunter Pharmaceutical Co., Ltd. reported a quarterly gross profit of 69.39 Million CNY for 2024 Q1, down -12.38% from previous quarter.

Annual Gross Profit Chart of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Gross Profit of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Gross Profit	Gross Profit Growth
2023	236.17 Million CNY	6.9%
2022	226.99 Million CNY	-2.2%
2021	232.09 Million CNY	-4.8%
2020	243.81 Million CNY	-24.16%
2019	321.46 Million CNY	-4.45%
2018	336.43 Million CNY	30.63%
2017	257.53 Million CNY	-5.34%
2016	272.06 Million CNY	0.29%
2015	271.29 Million CNY	24.4%
2014	218.07 Million CNY	43.35%
2013	152.12 Million CNY	40.94%
2012	107.93 Million CNY	20.2%
2011	89.79 Million CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	61.96 Million CNY	-10.71%
2024 Q3	65.86 Million CNY	6.3%
2024 Q1	69.39 Million CNY	-12.38%
2023 Q4	79.19 Million CNY	30.19%
2023 Q1	51.05 Million CNY	-6.08%
2023 Q2	51.59 Million CNY	1.07%
2023 Q3	60.82 Million CNY	17.89%
2023 FY	242.66 Million CNY	6.9%
2022 Q3	60.44 Million CNY	5.87%
2022 Q2	57.09 Million CNY	3.63%
2022 Q1	55.09 Million CNY	-13.27%
2022 Q4	54.35 Million CNY	-10.09%
2022 FY	226.99 Million CNY	-2.2%
2021 Q2	48.28 Million CNY	-21.75%
2021 Q4	63.52 Million CNY	8.44%
2021 Q3	58.58 Million CNY	21.32%
2021 FY	232.09 Million CNY	-4.8%
2021 Q1	61.7 Million CNY	-6.6%
2020 Q4	66.06 Million CNY	-1.04%
2020 FY	243.81 Million CNY	-24.16%
2020 Q1	53.93 Million CNY	-20.78%
2020 Q3	66.76 Million CNY	17.02%
2020 Q2	57.05 Million CNY	5.79%
2019 Q1	87.16 Million CNY	-9.43%
2019 Q4	68.07 Million CNY	-18.32%
2019 FY	321.46 Million CNY	-4.45%
2019 Q3	83.33 Million CNY	0.54%
2019 Q2	82.89 Million CNY	-4.91%
2018 Q2	65.59 Million CNY	-12.12%
2018 Q1	74.63 Million CNY	16.71%
2018 Q4	96.24 Million CNY	-3.71%
2018 FY	336.43 Million CNY	30.63%
2018 Q3	99.95 Million CNY	52.39%
2017 Q4	63.95 Million CNY	5.56%
2017 Q1	73.53 Million CNY	-0.57%
2017 FY	257.53 Million CNY	-5.34%
2017 Q2	59.45 Million CNY	-19.14%
2017 Q3	60.58 Million CNY	1.9%
2016 Q4	73.95 Million CNY	10.21%
2016 FY	272.06 Million CNY	0.29%
2016 Q3	67.1 Million CNY	12.19%
2016 Q2	59.81 Million CNY	-15.97%
2016 Q1	71.18 Million CNY	0.1%
2015 Q4	71.11 Million CNY	-3.0%
2015 FY	271.29 Million CNY	24.4%
2015 Q3	73.31 Million CNY	14.12%
2015 Q2	64.24 Million CNY	2.58%
2015 Q1	62.62 Million CNY	5.06%
2014 Q2	49.8 Million CNY	0.37%
2014 Q1	49.61 Million CNY	0.0%
2014 FY	218.07 Million CNY	43.35%
2014 Q4	59.6 Million CNY	0.94%
2014 Q3	59.05 Million CNY	18.58%
2013 FY	152.12 Million CNY	40.94%
2012 FY	107.93 Million CNY	20.2%
2011 FY	89.79 Million CNY	0.0%

Peer Gross Profit Comparison of Fujian Cosunter Pharmaceutical Co., Ltd.

Name	Gross Profit	Gross Profit Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	3.51 Billion CNY	93.287%
Anhui Fengyuan Pharmaceutical Co., Ltd.	1.09 Billion CNY	78.348%
Dong-E-E-Jiao Co.,Ltd.	3.31 Billion CNY	92.882%
Livzon Pharmaceutical Group Inc.	7.35 Billion CNY	96.79%
Hainan Haiyao Co., Ltd.	548.76 Million CNY	56.962%
Tus-Pharmaceutical Group Co., Ltd.	202.51 Million CNY	-16.624%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.69 Billion CNY	86.09%
Changchun High-Tech Industries (Group) Inc.	12.12 Billion CNY	98.052%
Apeloa Pharmaceutical Co.,Ltd	2.85 Billion CNY	91.721%
PKU HealthCare Corp.,Ltd.	711.92 Million CNY	66.826%
Chengdu Huasun Technology Group Inc., Ltd.	394.38 Million CNY	40.115%
Dezhan Healthcare Company Limited	292.55 Million CNY	19.27%
Jinling Pharmaceutical Company Limited	586.11 Million CNY	59.705%
Jiuzhitang Co., Ltd.	1.75 Billion CNY	86.512%
Huapont Life Sciences Co., Ltd.	4.38 Billion CNY	94.616%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	1.9 Billion CNY	87.594%
Shandong Wohua Pharmaceutical Co., Ltd.	652.87 Million CNY	63.825%
Hengkang Medical Group Co., Ltd.	1.07 Billion CNY	78.13%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	1.52 Billion CNY	84.56%
Qianjiang Yongan Pharmaceutical Co., Ltd.	229.27 Million CNY	-3.009%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	921.02 Million CNY	74.357%
Jinhe Biotechnology CO., LTD.	602.51 Million CNY	60.801%
Teyi Pharmaceutical Group Co.,Ltd	599.22 Million CNY	60.586%
Kunming Longjin Pharmaceutical Co., Ltd.	47.12 Million CNY	-401.206%
Beijing Aosaikang Pharmaceutical Co., Ltd.	1.16 Billion CNY	79.744%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	3.51 Billion CNY	93.289%
Anhui Huangshan Capsule Co., Ltd.	123.24 Million CNY	-91.626%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	568.08 Million CNY	58.426%
Zhuhai Rundu Pharmaceutical Co., Ltd.	606.85 Million CNY	61.082%
Huaren Pharmaceutical Co., Ltd.	699.05 Million CNY	66.215%
Tianjin Ringpu Bio-Technology Co.,Ltd.	1.11 Billion CNY	78.865%
Shanxi Zhendong Pharmaceutical Co.,Ltd	1.82 Billion CNY	87.07%
Fuan Pharmaceutical (Group) Co., Ltd.	1.36 Billion CNY	82.722%
Hybio Pharmaceutical Co., Ltd.	172.85 Million CNY	-36.63%
Baotou Dongbao Bio-Tech Co.,Ltd	245.98 Million CNY	3.986%
Hunan Er-Kang Pharmaceutical Co., Ltd	240.58 Million CNY	1.832%
Changjiang Pharmaceutical Group Co., Ltd.	172.9 Million CNY	-36.591%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	653.25 Million CNY	63.846%
Beijing Science Sun Pharmaceutical Co., Ltd.	335.63 Million CNY	29.632%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	111.6 Million CNY	-111.62%
Hainan Poly Pharm. Co., Ltd	952.97 Million CNY	75.217%
Jiangxi Synergy Pharmaceutical Co., Ltd.	220.35 Million CNY	-7.179%
Wuhan Hiteck Biological Pharma Co.,Ltd	232.55 Million CNY	-1.556%
Shandong Xinhua Pharmaceutical Company Limited	2.2 Billion CNY	89.306%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	849.83 Million CNY	72.209%
PharmaBlock Sciences (Nanjing), Inc.	695.45 Million CNY	66.04%
Jinghua Pharmaceutical Group Co., Ltd.	692.95 Million CNY	65.917%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	189.17 Million CNY	-24.846%
Betta Pharmaceuticals Co., Ltd.	2.05 Billion CNY	88.489%
Tibet AIM Pharm. Inc.	341.45 Million CNY	30.831%
Shenzhen Kangtai Biological Products Co., Ltd.	2.82 Billion CNY	91.631%
Shandong Shanda Wit Science and Technology Co., Ltd.	2.14 Billion CNY	88.99%
Pacific Shuanglin Bio-pharmacy Co., LTD	1.19 Billion CNY	80.3%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	725.35 Million CNY	67.44%
Xiamen Kingdomway Group Company	1.15 Billion CNY	79.606%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	541.83 Million CNY	56.411%
Walvax Biotechnology Co., Ltd.	3.43 Billion CNY	93.114%
Sunflower Pharmaceutical Group Co.,Ltd	3.07 Billion CNY	92.325%
Harbin Gloria Pharmaceuticals Co., Ltd	1.47 Billion CNY	83.99%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	13.01 Billion CNY	98.185%
Hunan Hansen Pharmaceutical Co., Ltd.	692.75 Million CNY	65.908%
Changzhou Qianhong Biopharma CO.,LTD	748.4 Million CNY	68.443%
Shenzhen Weiguang Biological Products Co., Ltd.	433.24 Million CNY	45.486%
Honz Pharmaceutical Co., Ltd.	443.79 Million CNY	46.783%
Northeast Pharmaceutical Group Co., Ltd.	3.03 Billion CNY	92.222%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.05 Billion CNY	77.557%
Guizhou Xinbang Pharmaceutical Co., Ltd.	1.11 Billion CNY	78.911%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	634.54 Million CNY	62.78%
Zhejiang Yatai Pharmaceutical Co., Ltd.	132.09 Million CNY	-78.787%
Zhejiang NHU Company Ltd.	4.75 Billion CNY	95.032%
ApicHope Pharmaceutical Co., Ltd	2.02 Billion CNY	88.359%
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.28 Billion CNY	81.571%
Beijing SL Pharmaceutical Co., Ltd.	712.85 Million CNY	66.869%
Yunnan Baiyao Group Co.,Ltd	10.15 Billion CNY	97.675%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	693.82 Million CNY	65.96%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	265.97 Million CNY	11.202%
Guangdong Lifestrong Pharmacy Co., Ltd.	200.45 Million CNY	-17.823%
Huadong Medicine Co., Ltd	12.53 Billion CNY	98.116%
Jiangsu Nhwa Pharmaceutical Co., LTD	3.6 Billion CNY	93.446%
Harbin Medisan Pharmaceutical Co., Ltd.	711.23 Million CNY	66.793%
LanZhou Foci Pharmaceutical Co.,Ltd.	361.29 Million CNY	34.631%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	3.11 Billion CNY	92.429%
Beijing Beilu Pharmaceutical Co., Ltd	373.52 Million CNY	36.771%
Nanjing Hicin Pharmaceutical Co., Ltd.	421.23 Million CNY	43.933%
Renhe Pharmacy Co., Ltd.	1.8 Billion CNY	86.938%
Chongqing Pharscin Pharmaceutical Co., Ltd.	380.19 Million CNY	37.88%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	2.15 Billion CNY	89.024%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	964.58 Million CNY	75.515%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	2.31 Billion CNY	89.777%

Global Stocks Search

Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ)

Gross Profit Summary of Fujian Cosunter Pharmaceutical Co., Ltd.

Annual Gross Profit Chart of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Gross Profit of Fujian Cosunter Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Gross Profit Comparison of Fujian Cosunter Pharmaceutical Co., Ltd.